DK0605474T3 - Carbamatanaloger af thiaphysovenin, farmaceutiske præparater og fremgangsmåder til inhibering af cholinesteraser - Google Patents

Carbamatanaloger af thiaphysovenin, farmaceutiske præparater og fremgangsmåder til inhibering af cholinesteraser

Info

Publication number
DK0605474T3
DK0605474T3 DK92919058T DK92919058T DK0605474T3 DK 0605474 T3 DK0605474 T3 DK 0605474T3 DK 92919058 T DK92919058 T DK 92919058T DK 92919058 T DK92919058 T DK 92919058T DK 0605474 T3 DK0605474 T3 DK 0605474T3
Authority
DK
Denmark
Prior art keywords
thiaphysovenin
methods
pharmaceutical preparations
compounds
cholinesterases
Prior art date
Application number
DK92919058T
Other languages
Danish (da)
English (en)
Inventor
Arnold Brossi
Xiao-Shu He
Stanley I Rapoport
Nigel H Greig
Malgarzota Brzostowska
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of DK0605474T3 publication Critical patent/DK0605474T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
DK92919058T 1991-09-26 1992-08-26 Carbamatanaloger af thiaphysovenin, farmaceutiske præparater og fremgangsmåder til inhibering af cholinesteraser DK0605474T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76576691A 1991-09-26 1991-09-26
US84508192A 1992-03-03 1992-03-03
PCT/US1992/007085 WO1993005779A1 (fr) 1991-09-26 1992-08-26 Carbamates analogues de la thiaphysovenine, compositions pharmaceutiques, et procede servant a inhiber les cholinesterases

Publications (1)

Publication Number Publication Date
DK0605474T3 true DK0605474T3 (da) 2004-02-23

Family

ID=27117648

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92919058T DK0605474T3 (da) 1991-09-26 1992-08-26 Carbamatanaloger af thiaphysovenin, farmaceutiske præparater og fremgangsmåder til inhibering af cholinesteraser

Country Status (10)

Country Link
US (1) US5378723A (fr)
EP (2) EP0605474B1 (fr)
JP (1) JP3193717B2 (fr)
AT (1) ATE254916T1 (fr)
AU (1) AU667318B2 (fr)
CA (1) CA2119782C (fr)
DE (1) DE69233255T2 (fr)
DK (1) DK0605474T3 (fr)
ES (1) ES2206449T3 (fr)
WO (1) WO1993005779A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL191402B1 (pl) * 1997-07-09 2006-05-31 Axonyx Związek będący selektywnym inhibitorem butyrylocholinesterazy, kompozycja farmaceutyczna zawierająca związek będący selektywnym inhibitorem butyrylocholinesterazy oraz zastosowanie inhibitora butyrylocholinesterazy
US6534541B1 (en) * 1999-10-19 2003-03-18 Novartis Ag Treatment of ocular disorders
EP1349858B1 (fr) * 2000-11-02 2008-08-27 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Agents permettant la reduction de la proteine precurseur amyloide et le traitement de la demence et procede d'utilisation de tels agents
EP1554572B1 (fr) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
WO2005074917A1 (fr) * 2004-01-30 2005-08-18 Axonyx, Inc. Methodes de traitement de complications du diabete
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
CA2663377A1 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hepatiques par l'administration de conjugues de proteine associee au recepteur (rap)
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
KR101667215B1 (ko) 2014-10-21 2016-10-18 한밭대학교 산학협력단 신규한 트립타민 컨쥬게이트 화합물 및 그의 용도
KR102233120B1 (ko) 2018-12-18 2021-03-29 한밭대학교 산학협력단 신규한 파에오놀-트립타민 화합물 및 그의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133930A (en) * 1961-08-15 1964-05-19 Ciba Geigy Corp Ester and amide derivatives of thieno-[3, 2-b] indole 3-carboxylic acids
US4900748A (en) * 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents

Also Published As

Publication number Publication date
JP3193717B2 (ja) 2001-07-30
EP1251131A3 (fr) 2002-10-30
AU2504292A (en) 1993-04-27
EP1251131A2 (fr) 2002-10-23
CA2119782A1 (fr) 1993-04-01
EP0605474A1 (fr) 1994-07-13
JPH07505120A (ja) 1995-06-08
CA2119782C (fr) 2005-08-23
WO1993005779A1 (fr) 1993-04-01
DE69233255D1 (de) 2004-01-08
EP0605474A4 (fr) 1994-08-03
AU667318B2 (en) 1996-03-21
DE69233255T2 (de) 2004-05-27
EP0605474B1 (fr) 2003-11-26
ATE254916T1 (de) 2003-12-15
ES2206449T3 (es) 2004-05-16
US5378723A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
DK658787A (da) Mycophenolsyrederivater
DK163120C (da) Analogifremgangsmaade til fremstilling af substituerede acylderivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyre (s,s,s) eller et farmaceutisk acceptabelt salt deraf
DK0457686T3 (da) Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
DE69332860D1 (de) Bicyklische fibrinogen antagoniste
DK0605474T3 (da) Carbamatanaloger af thiaphysovenin, farmaceutiske præparater og fremgangsmåder til inhibering af cholinesteraser
PT96916A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um macrolido
PT653427E (pt) Derivados de galantamina processo para a sua preparacao e sua utilizacao como medicamentos
ES524236A0 (es) Un procedimiento para la preparacion de 1,4-dihidropiridina
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
DK0402752T3 (da) N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
PT98362A (pt) Processo para a preparacao de derivados de tioalquiltio-cefalosporina e de composicoes farmaceuticas que os contem
PT96030A (pt) Processo para a preparacao de aminocarbonilcarbamatos relacionados com fisoestigmina e de composicoes farmaceuticas que os contem
OA09119A (fr) Nouveaux céphèmes et leur préparation.
MX9202975A (es) Nuevos compuestos biciclicos y sus sales farmaceuticamente aceptables y procedimiento para su preparacion.
DK0494604T3 (da) 1-Piperazinyl-2-butener og -2-butyner, mellemprodukter derfor, en fremgangsmåde til fremstilling deraf og deres anvendelse
EP0642504A4 (fr) Acides (3s,4s)-delta-6-tetrahydrocannabinol-7-oiques et derives de ces acides, procedes pour leur preparation et compositions pharmaceutiques contenant ces acides.
ATE63306T1 (de) Indolderivate.
FR2795072B1 (fr) Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FI954213A (fi) Kasvainten vastaisia koostumuksia ja hoitomenetelmiä
SE8601798L (sv) Forfarande for framstellning av eburnamenin-derivat
NO941757D0 (no) 1-fenylpyrrolidon-derivater med optisk aktivitet, mellomprodukter for fremstilling derav og fremgangsmåter for deres fremstilling